SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

by M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder
Published 2018-01-01